Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Are The Current (2025) And Forecast (2029) Sizes Of The Chromatin immunoprecipitation (ChIP) Sequencing Market?
Recent years have witnessed a rapid expansion in the size of the chromatin immunoprecipitation (chip) sequencing market. The market is projected to expand from $13.89 billion in 2024 to $15.48 billion in 2025, achieving a compound annual growth rate (CAGR) of 11.4%. This historical growth is largely due to factors such as improved understanding of gene regulation, the increasing prevalence of epigenetics studies, advancements in data analysis and bioinformatics tools, and enhanced cost efficiency and scalability.
The chromatin immunoprecipitation (chip) sequencing market is projected to experience substantial expansion over the next few years. This market is anticipated to reach $25.3 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 13.1%. The expansion during the forecast period is attributed to factors such as increased industry investment and competition, broader clinical adoption and diagnostic applications, a rising demand for biomarker discovery, rapid advancements in bioinformatics tools, and expanded applications within drug discovery. Key trends for the forecast period include clinical translation and diagnostic applications, a concentrated focus on histone modifications, the utilization of these techniques in novel research areas, ongoing advancements in sample preparation methods, and the integration of multi-omics data.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13265&type=smp
Which Drivers Are Impacting The Chromatin immunoprecipitation (ChIP) Sequencing Market?
The increasing incidence of prostate cancer is expected to drive the growth of the chromatin immunoprecipitation (ChIP) sequencing market going forward. Prostate cancer is a form of malignancy that develops within the prostate gland, a walnut-sized gland in men responsible for producing fluid that aids semen. In the context of prostate cancer research, ChIP-seq provides a comprehensive understanding of the molecular events propelling the disease, offering vital information that can lead to a deeper insight into its biology and facilitate the development of more targeted and effective therapeutic interventions. For instance, in January 2023, according to the American Cancer Society, a US-based cancer-fighting organization, it was estimated that there were 288,300 new cases of prostate cancer and 34,700 deaths from prostate cancer in the US in 2023. Therefore, the growing prevalence of prostate cancer is stimulating the expansion of the chromatin immunoprecipitation (ChIP) sequencing market.
How Is The Chromatin immunoprecipitation (ChIP) Sequencing Market Classified Into Different Segments?
The chromatin immunoprecipitation (chip) sequencingmarket covered in this report is segmented –
1) By Type: DNase-Sequencing; FAIRE-Sequencing
2) By Technology: Targeted Sequencing And Re-Sequencing; Whole Genome Sequencing And Whole Exome Sequencing
3) By Workflow: Pre-Sequencing; Sequencing; Data Analysis
4) By Application: Consumables And Reagents; Service; Other Applications
5) By End-User: Academic Research Institutes; Clinical Research Institutes; Hospitals And Clinics; Pharmaceuticals And Biotechnology Companies; Other End Users
Subsegments:
1) By DNase-Sequencing: DNase I Hypersensitivity Mapping; DNase-Seq For Open Chromatin Regions
2) By FAIRE-Sequencing: Formaldehyde-Assisted Isolation Of Regulatory Elements (FAIRE); FAIRE-Seq For Active Regulatory Regions
Which Key Trends Are Expected To Influence The Chromatin immunoprecipitation (ChIP) Sequencing Market In The Coming Years?
Leading firms within the chromatin immunoprecipitation (ChIP) sequencing market are prioritizing novel technologies, specifically hmqChIP-seq (high-throughput multiplex quantitative Chromatin Immunoprecipitation sequencing), to boost the effectiveness and precision of epigenomic studies, thereby propelling progress in drug development and tailored medical treatments. This hmqChIP-seq (high-throughput multiplex quantitative Chromatin Immunoprecipitation sequencing) represents a sophisticated approach engineered to improve the investigation of epigenetic changes throughout the genome. As an example, in June 2024, Epigenica, a life sciences technology company headquartered in Sweden, introduced its EpiFinder Platform. This platform incorporates proprietary hmqChIP-seq technology, enabling high-throughput, multiplex quantitative analyses for epigenomic investigations. Through this cutting-edge platform, scientists can concurrently produce 192 genome-wide profiles from a maximum of 24 samples, thereby optimizing extensive experiments with unparalleled velocity and economic efficiency.
Who Are The Top Performing Companies In The Chromatin immunoprecipitation (ChIP) Sequencing Market In Recent Years?
Major companies operating in the chromatin immunoprecipitation (chip) sequencing market report are F. Hoffmann La Roche Ltd., Merck KGaA, Thermo Fisher Scientific Inc., Becton Dickinson and Co., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Bio-Techne Corp., BGI Genomics Co. Ltd., Promega Corporation, GenScript Biotech Corporation, Abcam PLC, BioLegend Inc., Hamilton Co., Takara Bio Inc., Novogene Co. Ltd., Oxford Nanopore Technologies PLC, Porvair Sciences Ltd., Creative Biolabs Inc., Cell Signaling Technology Inc., GENEWIZ Inc., Zymo Research Corporation, CD Genomics, Active Motif Inc., Psomagen Inc., EpiCypher Inc.
Download The Full Report For Exclusive Market Findings:
How Does The Chromatin immunoprecipitation (ChIP) Sequencing Market Perform Across Key Geographic Regions?
North America was the largest region in the chromatin immunoprecipitation (ChIP) sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chromatin immunoprecipitation (chip) sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request A Customized Version Of The Chromatin immunoprecipitation (ChIP) Sequencing Market Report:
https://www.thebusinessresearchcompany.com/customise?id=13265&type=smp
Browse Through More Reports Similar to the Global Chromatin immunoprecipitation (ChIP) Sequencing Market 2025, By The Business Research Company
Clinical Oncology Next Generation Sequencing Global Market Report 2025
Ngs Based Rna Sequencing Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report
Prenatal Dna Sequencing Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/prenatal-dna-sequencing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model